Search results
Results From The WOW.Com Content Network
The national drug policy of Switzerland was developed in the early 1990s and comprises the four elements of prevention, therapy, harm reduction and prohibition. [54] In 1994 Switzerland was one of the first countries to try heroin-assisted treatment and other harm reduction measures like supervised injection rooms.
The Global Commission on Drug Policy (GCDP) is a panel of world leaders and intellectuals, with a secretariat based in Geneva, Switzerland. [1]In June 2011, the commission said: "The global war on drugs has failed, with devastating consequences for individuals and societies around the world."
Drugs for medical conditions that must be monitored (e.g. chemotherapy). Drugs that should only be taken for a limited duration. The prescription can be redeemed only once, though repeated purchase of the drug is possible since 2018. tramadol, amoxicillin, ritonavir, lenalidomide: B: Drugs which can cause health damage even under correct use.
The 4 pillars of Switzerland's drug policy: prevention, treatment, harm reduction and repression. The revision of the federal statute on narcotics ...
[45] [46] Personal consumption and possession of small amounts, or sharing with adults free of charge is not liable to prosecution based on the Swiss federal law. [47] Sweden: Illegal: Illegal: Illegal: Illegal: Sweden is known and infamous for having a zero tolerance policy regarding drug trafficking and drug abuse. Thailand: Illegal: Illegal ...
Cannabis that contains more than 1.0% THC is classified as an illegal drug in Switzerland. [2] Thus, according to the Federal Narcotics Act: the production, culture, use, and possession of cannabis, are all prohibited and considered as criminal infringements. [3]
The Incepta drugs are part of an Asia-based supply chain manufacturing and exporting cheaper copies of Ozempic across the world, Reuters has found, driven by a spike in global demand for the drug.
Swissmedic is a federal institution subject to public law and was created by the Federal Act on Medicinal Products and Medical Devices. [1] It is independent in organization and management and has authority over its own budget.